Baricitinib is used to treat arthritis, both alone and in combination with methotrexate. The compound is a reversible inhibitor of Janus kinase enzymes. Baricinitib was approved for use in the EU in 2017, but the USFDA has refused to approve the drug, citing concerns over safety and dosage. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / GREG WILLIAMS |
Bildgröße: | 4002 px × 4366 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: | - |